Intensified telematic treatment for obesity - drop out rates and predictors at 6 months of PREDIRCAM2 web intervention

PREDIRCAM2 is a web-platform for obesity treatment and fol low-up. A mul t icenter randomized-trial evaluates its effectiveness in obesity treatment and cardio-metabolic-risk prevention. Participants were randomized to an intensified-technological-intervention (TI) supported by PREDIRCAM2, or a traditional non-technological faceto- face-intensified-intervention (NTI). Both groups receive one year followup, 12 appointments